PROCEPT BioRobotics Corporation (NASDAQ: PRCT) reported Q2 EPS of ($0.56), $0.01 better than the analyst estimate of ($0.57). Revenue for the quarter came in at $33.1 million versus the consensus estimate of $30.31 million.

For earnings history and earnings-related data on PROCEPT BioRobotics Corporation (PRCT) click here.